baber/WOPTO huggingface dataset:
Patent NZ-201890-A (NZ)
Title: Apparatus for automatically dispensing liquid chemicals into an intermittenly flowing liquid stream
Inventor: KLEPA P P
IPC: F04B13/02
Filed: 1982-09-13
Abstract: Apparatus (10) for automatically dispensing a liquid treatment chemical (12) from a replaceable supply bottle (14) into an intermittently flowing liquid stream (22) such as a recirculating water supply for a refrigeration system. The apparatus has a feeder chamber (16) into which the liquid stream (22) flows which is periodically emptied by a siphon tube (18) when the liquid reaches a level sufficient to establish a siphon effect in the siphon tube (18). The rising level of liquid (22) in the chamber (16) also actuates, by means of a float (24), the valve portion (31) of a closure assembly (30) on the inverted top of the supply bottle (14). The valve portion (31) is fed by a capillary tube (50) and dispenses a predetermined, very small quantity of chemical each time it is actuated. The valve portion (31) is prevented from becoming clogged by chemical crystals during inactive periods by being mounted so that its surface will be flushed each cycle by the water (22) which rises in the feeder chamber (16).
Patent NZ-204657-A (NZ)
Title: Swathe former:gearbox drive for opposite raking directions
Inventor: QUATAERT P M
IPC: A01D78/10
Filed: 1983-06-21
Abstract: The machine for treating crops lying on the ground has a beam (1) which is attached to a tractor (4) by a bar (2) so that the beam is oblique to the direction of travel. One end of the beam supports a rotary rake (6) with tines (7). A second similar rotary rake (14) is suspended from a frame attached to the beam so that it lies behind the first rake. The frame is so designed that it can be attached to the opposite side of the beam so that the two rakes lie side by side on a line at right angles to the direction of travel.
Patent NZ-222607-A (NZ)
Title: Heterocyclic - phosphonic acids, preparation therof and pharmaceutical compositions
Inventor: HUTCHISON ALAN J
IPC: C07F9/547
Filed: 1987-11-19
Abstract: Compounds of the formula I <IMAGE> in which one or both of the acidic hydroxyl groups of the phosphonic acid part can be etherified, m is one or zero, R<1> denotes carboxyl, esterified carboxyl or amidated carboxyl, the heterocyclic five- or six-membered ring can additionally be substituted on the carbon and/or nitrogen, can have a carbon-carbon double bond or can be condensed with a carbocyclic 6-membered ring, starting from adjacent carbon atoms, A represents lower alkenylene; and salts thereof. These compounds are suitable as antagonists of the N-methyl-D-aspartate- sensitive amino acid stimulant receptor in mammals.
Patent NZ-224114-A (NZ)
Title: 2-mercapto-5-pyridyl-1,3,4(oxa- or thia-)diazoles as nematocides
Inventor: NYFELER ROBERT
IPC: C07D417/04
Filed: 1988-03-31
Abstract: There are described 2-mercapto-5-pyridyl-1,3,4-oxadiazoles and 2-mercapto-5-pyridyl-1,3,4-thiadiazoles of the formula I 
<IMAGE>
 in which
 X represents oxygen or sulphur,
 R' represents C1-C3-alkyl which is substituted by bromine, fluorine, C1-C3-alkoxy or cyano, C3-C7-alkenyl which is unsubstituted or substituted by halogen; C4-C7-alkynyl which is unsubstituted or substituted by halogen,
 R represents C1-C3-alkyl, C1-C3-alkoxy which is unsubstituted or substituted by halogen or C1-C3-alkoxy; C3-C7-alkenyl which is unsubstituted or substituted by halogen; C3-C7-alkynyl, C1-C3-alkylthio, halogen, cyano, hydroxyl, amino which is unsubstituted or monosubstituted or disubstituted by C1-C3-alkyl; or aminocarbonyl, and
 n represents 0, 1, 2, 3 or 4, the process for the preparation of the compounds of the formula I, and novel intermediates of the process. 
<??>The compounds of the formula I have nematicidal properties. There are described nematicidal agents which contain, as active substance, at least one active substance of the formula I, and furthermore processes for the use of the active substances and the agents in the control of nematodes.
Patent NZ-225546-A (NZ)
Title: Pharmaceutical compositions containing ghrh and a cholinergic agonist
Inventor: BOGHEN FRANKLIN M
IPC: A61K9/06
Filed: 1988-07-25
Abstract: A pharmaceutical composition for intranasal administration comprising GHRH, a cholinergic agonist and in case a bile salt, suitable for the treatment of growth disorders and for use in the diagnosis of GH hypophyseal functionality.
Patent NZ-232389-A (NZ)
Title: Thio ether derivatives of aminoalkoxyphenyl compounds and pharmaceutical compositions
Inventor: GUBIN JEAN
IPC: C07D213/70
Filed: 1990-02-05
Abstract: The invention relates to aminoalkoxyphenyl derivatives which are active, in particular, in the treatment of pathological syndromes of the cardiovascular system, corresponding to the general formula: <IMAGE> as well as their pharmaceutically acceptable salts, in which formula:  B represents an -S-, -SO- or -SO2- group, R1 and R2, which are identical or different, each represent hydrogen, a methyl or ethyl radical or a halogen such as chlorine, bromine or iodine, A represents a linear or branched alkylene radical having from 2 to 5 carbon atoms or a 2-hydroxypropylene radical in which the hydroxyl is optionally substituted with a lower alkyl radical,  Am represents a group: <IMAGE> and Cy represents a group of formula: <IMAGE>
Patent NZ-237450-A (NZ)
Title: The use of 5-chloro-2,3-dihydro-2-oxo-3-(2-thienylcarbonyl)indole-1-carboxamide (tenidap) in the preparation of a pharmaceutical composition
Inventor: LOOSE LELAND DAVID
IPC: A61P9/00
Filed: 1991-03-15
Abstract: This invention relates to the use of tenidap, 5-chloro-2,3-dihydro-2-oxo-3-(2-thienylcarbonyl)-indole-1-carboxamide, and the pharmaceutically-acceptable base salts thereof to inhibit the release of elastase by neutrophils in a mammal. This invention also relates to the use of tenidap and its salts for treating elastase-mediated diseases and dysfunctions such as arteritis, proteinuria and pulmonary emphysema in mammals. The methods of this invention comprise administering an effective amount of tenidap or salts thereof to a mammal.
Patent NZ-245122-A (NZ)
Title: Highly filled curable composition comprising addition polymerisable monomer, filler, a functionalised polymeric material soluble in the monomer but forming a separate phase after cure and a dispersing agent
Inventor: ASHTON DAVID PIERS
IPC: C08K3/00
Filed: 1992-11-13
Abstract: A polymeric dispersant having a low Tg polymer component, e.g. polybutadiene, and a pendant silylated group with hydrolysable groups capable of associating with and dispersing. finely divided inorganic fillers. Curable compositions containing the polymeric dispersant can be cured into composite materials having improved resistance to stress induced by thermal cycling.
Patent NZ-332586-A (NZ)
Title: Suppression of endogenous gene and replacement of suppressed gene sequence
Inventor: FARRAR GWENYTH JANE
IPC: A61K38/00
Filed: 1997-04-02
Abstract: The use of a suppressing endogenous gene product in the manufacture of a medicament for treatment of autosomal dominant diseases by introducing a replacement gene. The gene is introduced by: 1) providing suppressing nucleic acids or other suppression effectors able to bind to an endogenous gene, gene transcript or gene product to be suppressed, and 2) providing genomic DNA or cDNA (complete or partial) encoding a replacement gene wherein the suppressing nucleic acids are unable to bind to equivalent regions in the genomic DNA or cDNA to prevent expression of the replacement gene. The replacement nucleic acids have modifications in one or more third base (wobble) positions such that replacement nucleic acids still code for the wild type or equivalent amino acids.
Patent NZ-332904-A (NZ)
Title: Compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
Inventor: SALINI ALBERTO
IPC: A61K38/00
Filed: 1997-05-20
Abstract: Pharmaceutical compositions containing cyclosporine combined with a carrier comprising an ester of 'alpha'-glycerophosphoric acid, increasing cyclosporine bioavailability.
Patent NZ-334939-A (NZ)
Title: Corrugator belt for corrugating machine with layer of polymeric material on face side to increase friction
Inventor: LANTHIER JOSEPH D
IPC: B31F1/20
Filed: 1999-03-30
Abstract: A corrugator belt for a corrugator machine includes a base (42) having two sides. One of the two sides is the face side of the corrugator belt when the belt is in the form of an endless loop on a corrugator machine. A layer of polymeric resin (90) material is coated onto the face side of the base. The polymeric resin material provides the corrugator belt with an increased coefficient of friction relative to corrugated board, enabling the belt to pull corrugated board more readily through a corrugator machine. <IMAGE>
Patent NZ-500864-A (NZ)
Title: Isolated nucleic acid molecules encoding human defensin peptide
Inventor: OLSEN HENRIK S
IPC: C07K16/18
Filed: 1998-05-14
Abstract: An isolated polynucleotide comprising a nucleic acid at least 95% identical to a reference nucleic acid encoding amino acids 1 to 41 of SEQ ID NO:2
Patent NZ-504036-A (NZ)
Title: Joint brace hinge with a slideable switch to allow the hinge to be repositioned , switch having stop mechanism engagebale with cammed surface to limit rotation of the hinge
Inventor: TILLINGHAST THEODORE
IPC: F16C11/10
Filed: 1998-10-19
Abstract: Hinges (12) for orthopaedic and rehabilitation braces allow intuitive, convenient and positive control and adjustment of the limits to which the braces (10) may extend or flex. Such hinges (12) also allow convenient locking of such braces (10). A flexion switch (24) and an extension switch (26) allow convenient repositioning of stops (56) or limits, which limit flexion and extension of the brace (10). Such switches (24, 26) may be repositioned, however, only with repositioning pressure for moving the switch (24, 26) to a new position combined with safety pressure for unlocking the switch (24, 26). A brace-locking switch may also be included. Such hinges (12) promote more effective post-operative and rehabilitation results because they, among other things, allow users easily to change the flexion, extension and fixation limitations of their braces (10) conveniently and in real time such as during post-operative and physical therapy sessions and workouts.
Patent NZ-504616-A (NZ)
Title: Process for the preparation of difluoromethane
Inventor: CERRI GUSTAVO
IPC: C07C17/20
Filed: 1998-11-18
Abstract: A process for preparing difluoromethane by: a) reacting methylene chloride and hydrogen fluoride in a reactor made of a fluorinated polymer to produce a reaction product; and b) feeding concurrently a heated recycle stream of process reactants into the reactor.
Patent NZ-505596-A (NZ)
Title: Fungicidal mixtures based on amide compounds and morpholine or piperidine derivatives
Inventor: SCHELBERGER KLAUS
IPC: A01N43/84
Filed: 1998-12-15
Abstract: Fungicide mixtures containing, as active components: (a) an amide compound of formula (I) A-CO-NR1R2, wherein A represents an aryl group or an aromatic or non-aromatic, 5- or 6-membered heterocycle compound having 1 to 3 hetero atoms selected from O, N, S; whereby the aryl group or the heterocyclic compound can optionally comprise 1, 2 or 3 substituents selected independently of one another from alkyl, halogen, CHF2, CF3, alkoxyl, haloalkoxyl, alkylthio, alkylsulfinyl and alkylsulfonyl; R1 is a hydrogen atom; R2 represents a phenyl group or cycloalkyl group optionally containing 1, 2 or 3 substituents selected independently of one another from alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, cycloalkyl, cycloalkenyl, cycolalkyloxy, cycloalkenyloxy, phenyl and halogen, whereby the aliphatic and cycloaliphatic radicals may be partially or completely halogenated and/or the cycloaliphatic radicals can be substituted by 1 to 3 alkyl groups, and where the phenyl group can contain 1 to 5 halogen atoms and/or 1 to 3 substituents selected independently of one another from alkyl, haloalkyl, alkoxy, haloaloxy, alkylthio and haloalkylthio, and where the amidic phenyl group is optionally condensed with a saturated 5-structured ring which is optionally substituted by one or more alkyl groups and/or can comprise a heteroatom selected from O and S; and (b) A morpholine derivative or piperidine derivative (II) selected from the group of compounds (IIa), (IIb) and (IIc) in a synergistically effective amount.
Patent NZ-508327-A (NZ)
Title: Thermoplastic pipe lining in which the pipe has been lubricated prior to the lining being applied
Inventor: MCGUIRE BRIAN EDWARD
IPC: F16L55/165
Filed: 1998-06-10
Abstract: A lining method for a host pipe (10) including lubrication of the host pipe prior to insertion of a thermoplastic liner (11) using tight fit techniques. After allowing the inserted liner to relax, the liner is partially pulled from within the host pipe using puller (20) and clamped with an internal clamp (30) to allow fitting of a special flange (40) to the liner (11) by butt fusion, for example. Thereafter the liner is allowed to revert so as to abut a flange (12) fitted to the host pipe (10). The technique is repeated at the other pipe end.
Patent NZ-509193-A (NZ)
Title: Molecular markers in ryegrass and fescues
Inventor: FORSTER JOHN WHITE
IPC: C07H21/04
Filed: 2001-01-03
Abstract: Simple sequence repeats (SSRs) are identified in ryegrasses and fescues.  Primers suitable for amplifying SSRs, methods for identifying SSRs and libraries enriched for SSRs are provided.  The SSRs may be used in the selection of genes in grass or cereal breeding, for profiling grass or cereal species varieties or for testing the purity of grass or cereal seed batches.
Patent NZ-520938-A (NZ)
Title: Therapeutic combinations of antihypertensive and antiangiogenic agents
Inventor: CURWEN JON OWEN
IPC: A61P29/00
Filed: 2001-04-02
Abstract: The invention concerns the use of a combination of an anti-angiogenic agent and an anti-hypertensive agent for use in the manufacture of a medicament for the treatment of a disease state associated with angiogenesis in a warm-blooded mammal, such as a human being. The invention also relates to pharmaceutical compositions comprising an anti-angiogenic agent and an anti-hypertensive agent, to kits thereof and to a method of treatment of a disease state associated with angiogenesis which comprises the administration of an effective amount of a combination of an anti-angiogenic agent and an anti-hypertensive agent to a warm-blooded animal, such as a human being.
Patent NZ-527132-A (NZ)
Title: Use of an insulin sensitiser to treat type 2 diabetes mellitus
Inventor: BENINCOSA LISA
IPC: C07D277/34
Filed: 1999-11-12
Abstract: A modified release pharmaceutical composition comprises 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier. The composition is adapted to provide a plasma concentration of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione within the range of from 40 to a level at or above 130 ng/mL over a sustained period of time such as a time period of up to 24 hours. The composition can be a delayed, pulsed or sustained release composition. (62) Divided out of 511610
Patent NZ-527847-A (NZ)
Title: New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
Inventor: BERNARDELLI PATRICK
IPC: C07D487/12
Filed: 2002-03-18
Abstract: Spirotricyclic derivative compounds of formula (I) that are phosphodiesterase-7 (PDE7) inhibitors, and methods for preparing these compounds are disclosed, wherein A, X1, X2, X3, X4, X, Y, and Z are as defined in the specification. These compounds are suitable for the treatment of disorders for which therapy by a PDE7 inhibitor is relevant.
Patent NZ-528635-A (NZ)
Title: Pharmaceutically active fused thiophene compounds and methods of use
Inventor: BARALDI PIER GIOVANNI
IPC: A61P25/02
Filed: 2002-03-29
Abstract: Disclosed are compounds of formula I to formula IX, for which the substituents are defined herein. The compounds are used for the manufacture of medicaments for treating a mammal suffering from or susceptible to chronic pain, cardiac disease or disorder, neurological disease or injury, sleep disorder, diabetes, disease associated with hyper-excited sensory nerve function, or an inflammatory condition.
Patent NZ-531376-A (NZ)
Title: Resilient product with hard interlayer secured by fusion welding, typically for sealing or resilient mounting member
Inventor: MILLS NORMAN ROSS
IPC: B60J10/80
Filed: 2002-06-24
Abstract: Disclosed is a resilient product including a relatively soft working section (2) secured to a surface of a relatively hard interlayer (4). An opposed surface of the interlayer includes a mounting section (3) which functions to secure the resilient product to a support. The resilient product is particularly suitable for providing a sealing member or a resilient mounting member. The ability of the resilient product to be secured to a support, and remain secured to that support is a particular advantage.
Patent NZ-532112-A (NZ)
Title: PH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery
Inventor: SEO MIN-HYO
IPC: C08G63/06
Filed: 2002-10-17
Abstract: Polylactic acid derivatives capable of forming micelles in an aqueous solution with a pH of 4 or above, having one terminal carboxyl group are disclosed. The polylactic acid derivatives may be applied as a drug delivery system in various forms since poorly water soluble drugs can be entrapped inside the micelles.
Patent NZ-533422-A (NZ)
Title: Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
Inventor: LAGRANDERIE MICHELINE
IPC: A61K35/74
Filed: 2002-12-11
Abstract: Use of a composition containing bacterial cells or an extract thereof wherein said bacterial cells consist of non-denatured killed Mycobacterium bovis BCG cells, and said composition is able to induce a modulation of the immune response against a self antigen or an allergen, for the preparation of a medicament for the prevention and/or the treatment of a disease selected from the group consisting of autoimmune disease and allergy.
Patent NZ-534821-A (NZ)
Title: Pyranones useful as ATM inhibitors
Inventor: SMITH GRAEME CAMERON MURRAY
IPC: C07D411/04
Filed: 2003-02-24
Abstract: Disclosed is a compound of formula (I) wherein: One of P and Q is O and the other is CH where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R3 group; Y is either O or S R1, R2 and R3 are as defined in the specification. Compounds of the type disclosed are useful in the treatment of retroviral mediated diseases or diseases ameliorated by the inhibition of ATM (ataxia telangiectasia mutated) including acquired immunodeficiency syndrome.
Patent NZ-535216-A (NZ)
Title: Programming interface for a computer platform
Inventor: BOGDAN JEFFREY L
IPC: G06F9/44
Filed: 2004-09-09
Abstract: A programming interface embodied on one or more computer readable media is disclosed. The programming interface includes (a) a first group of services related to generating graphical objects, (b) a second group of services related to formatting content, and (c) a third group of services related to creating components of the graphical objects. The first group of services, the second group of services and the third group of services utilise a common markup language and share a common programming model.
Patent NZ-537570-A (NZ)
Title: Spinal implant
Inventor: BRAZENOR GRAEME
IPC: A61F2/00
Filed: 2003-07-21
Abstract: Spinal implant for retaining spinal elements in desired spatial relationship. The implant includes a tensioning member (12) positionable along spinal column of patient to match contour thereof. A pair of buttress members (14, 16) are located each on one of the ends of tensioning member, at least one of the buttress members being slidable on tensioning member so distance between buttress members may be adjusted.
Patent NZ-538741-A (NZ)
Title: Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
Inventor: JERUSSI THOMAS P
IPC: A61P25/16
Filed: 2003-09-16
Abstract: Disclosed is desmethylsertaline (norsertraline) in the trans configuration as shown in formulae P and Q and the use of the compound in the manufacture of a medicament for treating a CNS disorder and the prophylaxis of a migraine. Also disclosed is the use in combination with an anti-psychotic for the manufacture of a medicament for the treatment of psychosis and methods and intermediates for making compounds of formulae P and Q.
Patent NZ-539649-A (NZ)
Title: Claudin-18 gene and protein and related compositions and uses thereof
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2003-11-21
Abstract: Disclosed is a pharmaceutical composition, comprising one or more components selected from the group consisting of: (i) a tumor-associated antigen or a functional fragment thereof, (ii) a nucleic acid which codes for a tumor-associated antigen or a functional fragment thereof, (iii) an antibody which binds to a tumor-associated antigen or a functional fragment thereof, (iv) an antisense nucleic acid which hybridizes specifically with a nucleic acid coding for a tumor-associated antigen, (v) an isolated host cell which expresses a tumor-associated antigen or a functional fragment thereof, and (vi) isolated complexes between a tumor-associated antigen or a functional fragment thereof and an HLA molecule, said tumor-associated antigen having a sequence encoded by a nucleic acid which is selected from the group consisting of: (a) a nucleic acid which comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 7 and 8, a fragment or derivative thereof, wherein said fragment or derivative thereof encodes a functional fragment or functional derivative of the tumor-associated antigen encoded by the nucleic acid sequence, (b) a nucleic acid which hybridizes with the nucleic acid of (a) under stringent conditions, (c) a nucleic acid which is degenerate with respect to the nucleic acid of (a) or (b), and (d) a nucleic acid which is complementary to the nucleic acid of (a), (b) or (c).
Patent NZ-540883-A (NZ)
Title: Structural wall framework
Inventor: TADICH JOHN
IPC: E04B1/26
Filed: 2005-06-21
Abstract: A building framework is disclosed which comprises studs 12 and 14. The studs 12 and 14 are coupled together by separate bracing elements 16 and 17. The studs 12 and 14 and bracing elements 16 and 17 form a bracing unit 10. The bracing unit 10 is provided between a top plate 51 and bottom plate 52 (see figure 4). The bracing elements 16 and 17 extend substantially all of the way from the top plate 51 to the bottom plate 52 and have integrally formed teeth for connection to the studs. The bracing unit may have more studs, such as bracing unit 20 (see figure 2) comprising three studs 22, 24, and 26.